{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:02:34Z","timestamp":1793764954518,"version":"4.6.1"},"reference-count":306,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41575-025-01129-w","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:57:56Z","timestamp":1760972276000},"page":"6-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Proteases in intestinal health and disease"],"prefix":"10.1038","volume":"23","author":[{"given":"Celine","family":"Deraison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1825-6015","authenticated-orcid":false,"given":"Nathalie","family":"Vergnolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"1129_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0014-5793(01)02490-5","volume":"498","author":"C Southan","year":"2001","unstructured":"Southan, C. A genomic perspective on human proteases. FEBS Lett. 498, 214\u2013218 (2001).","journal-title":"FEBS Lett."},{"key":"1129_CR2","doi-asserted-by":"publisher","first-page":"140345","DOI":"10.1016\/j.bbapap.2019.140345","volume":"1868","author":"ND Rawlings","year":"2020","unstructured":"Rawlings, N. D. Twenty-five years of nomenclature and classification of proteolytic enzymes. Biochim. Biophys. Acta Proteins Proteom. 1868, 140345 (2020).","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"1129_CR3","doi-asserted-by":"publisher","first-page":"30433","DOI":"10.1074\/jbc.R800035200","volume":"283","author":"C Lopez-Otin","year":"2008","unstructured":"Lopez-Otin, C. & Bond, J. S. Proteases: multifunctional enzymes in life and disease. J. Biol. Chem. 283, 30433\u201330437 (2008).","journal-title":"J. Biol. Chem."},{"key":"1129_CR4","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/gutjnl-2015-309147","volume":"65","author":"N Vergnolle","year":"2016","unstructured":"Vergnolle, N. Protease inhibition as new therapeutic strategy for GI diseases. Gut 65, 1215\u20131224 (2016).","journal-title":"Gut"},{"key":"1129_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1053\/j.gastro.2010.12.050","volume":"140","author":"J-P Motta","year":"2011","unstructured":"Motta, J.-P. et al. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology 140, 1272\u20131282 (2011).","journal-title":"Gastroenterology"},{"key":"1129_CR6","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1111\/bph.16341","volume":"181","author":"S Guignard","year":"2024","unstructured":"Guignard, S. et al. Chymotrypsin activity signals to intestinal epithelium by protease-activated receptor-dependent mechanisms. Br. J. Pharmacol. 181, 2725\u20132749 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2036.2000.00690.x","volume":"14","author":"N Vergnolle","year":"2000","unstructured":"Vergnolle, N. Review article: proteinase-activated receptors \u2014 novel signals for gastrointestinal pathophysiology. Aliment. Pharmacol. Ther. 14, 257\u2013266 (2000).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1129_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1471-4892(01)00099-6","volume":"1","author":"F Schmidlin","year":"2001","unstructured":"Schmidlin, F. & Bunnett, N. W. Protease-activated receptors: how proteases signal to cells. Curr. Opin. Pharmacol. 1, 575\u2013582 (2001).","journal-title":"Curr. Opin. Pharmacol."},{"key":"1129_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00726-022-03123-x","volume":"54","author":"NP Hyland","year":"2022","unstructured":"Hyland, N. P., Cavanaugh, C. R. & Hornby, P. J. Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function. Amino Acids 54, 57\u201370 (2022).","journal-title":"Amino Acids"},{"key":"1129_CR10","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1248\/bpb.33.1796","volume":"33","author":"T Tsurugizawa","year":"2010","unstructured":"Tsurugizawa, T. & Torii, K. Physiological roles of glutamate signaling in gut and brain function. Biol. Pharm. Bull. 33, 1796\u20131799 (2010).","journal-title":"Biol. Pharm. Bull."},{"key":"1129_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","volume":"42","author":"IS Afonina","year":"2015","unstructured":"Afonina, I. S., Muller, C., Martin, S. J. & Beyaert, R. Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42, 991\u20131004 (2015).","journal-title":"Immunity"},{"key":"1129_CR12","doi-asserted-by":"publisher","first-page":"28132","DOI":"10.1074\/jbc.M312785200","volume":"279","author":"KC Ingham","year":"2004","unstructured":"Ingham, K. C., Brew, S. A. & Erickson, H. P. Localization of a cryptic binding site for tenascin on fibronectin. J. Biol. Chem. 279, 28132\u201328135 (2004).","journal-title":"J. Biol. Chem."},{"key":"1129_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0962-8924(03)00129-6","volume":"13","author":"S Schenk","year":"2003","unstructured":"Schenk, S. & Quaranta, V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol. 13, 366\u2013375 (2003).","journal-title":"Trends Cell Biol."},{"key":"1129_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899456","volume":"37","author":"SF Lichtenthaler","year":"2018","unstructured":"Lichtenthaler, S. F., Lemberg, M. K. & Fluhrer, R. Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments. EMBO J. 37, e99456 (2018).","journal-title":"EMBO J."},{"key":"1129_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/ijms18020342","volume":"18","author":"MJ Stone","year":"2017","unstructured":"Stone, M. J., Hayward, J. A., Huang, C., Zil, E. H. & Sanchez, J. Mechanisms of regulation of the chemokine-receptor network. Int. J. Mol. Sci. 18, 342 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1129_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fendo.2014.00067","volume":"5","author":"P Zhao","year":"2014","unstructured":"Zhao, P., Metcalf, M. & Bunnett, N. W. Biased signaling of protease-activated receptors. Front. Endocrinol. 5, 67 (2014).","journal-title":"Front. Endocrinol."},{"key":"1129_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/2326-6066.CIR-16-0141","volume":"5","author":"HL Peters","year":"2017","unstructured":"Peters, H. L. et al. Serine proteases enhance immunogenic antigen presentation on lung cancer cells. Cancer Immunol. Res. 5, 319\u2013329 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"1129_CR18","doi-asserted-by":"publisher","first-page":"10295","DOI":"10.1074\/jbc.M116.773051","volume":"292","author":"C Kerros","year":"2017","unstructured":"Kerros, C. et al. Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells. J. Biol. Chem. 292, 10295\u201310305 (2017).","journal-title":"J. Biol. Chem."},{"key":"1129_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11, 5120 (2020).","journal-title":"Nat. Commun."},{"key":"1129_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/biom12020306","volume":"12","author":"JS Ramirez-Larrota","year":"2022","unstructured":"Ramirez-Larrota, J. S. & Eckhard, U. An introduction to bacterial biofilms and their proteases, and their roles in host infection and immune evasion. Biomolecules 12, 306 (2022).","journal-title":"Biomolecules"},{"key":"1129_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11140-w","volume":"10","author":"JP Motta","year":"2019","unstructured":"Motta, J. P. et al. Active thrombin produced by the intestinal epithelium controls mucosal biofilms. Nat. Commun. 10, 3224 (2019).","journal-title":"Nat. Commun."},{"key":"1129_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/gut.51.4.540","volume":"51","author":"MT Salmela","year":"2002","unstructured":"Salmela, M. T. et al. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation. Gut 51, 540\u2013547 (2002).","journal-title":"Gut"},{"key":"1129_CR23","doi-asserted-by":"publisher","first-page":"G116","DOI":"10.1152\/ajpheart.00036.2002","volume":"284","author":"C Medina","year":"2003","unstructured":"Medina, C. et al. Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G116\u2013G122 (2003).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.dld.2005.02.011","volume":"37","author":"Q Gao","year":"2005","unstructured":"Gao, Q. et al. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Dig. Liver Dis. 37, 584\u2013592 (2005).","journal-title":"Dig. Liver Dis."},{"key":"1129_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1042\/BJ20040058","volume":"381","author":"K Ogawa","year":"2004","unstructured":"Ogawa, K., Chen, F., Kuang, C. & Chen, Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem. J. 381, 413\u2013422 (2004).","journal-title":"Biochem. J."},{"key":"1129_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41385-021-00375-w","volume":"14","author":"JP Motta","year":"2021","unstructured":"Motta, J. P. et al. Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation. Mucosal Immunol. 14, 667\u2013678 (2021).","journal-title":"Mucosal Immunol."},{"key":"1129_CR27","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1096\/fj.06-7938com","volume":"21","author":"M Sariahmetoglu","year":"2007","unstructured":"Sariahmetoglu, M. et al. Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J. 21, 2486\u20132495 (2007).","journal-title":"FASEB J."},{"key":"1129_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071794","volume":"8","author":"AL Jacob-Ferreira","year":"2013","unstructured":"Jacob-Ferreira, A. L. et al. Phosphorylation status of 72\u2009kDa MMP-2 determines its structure and activity in response to peroxynitrite. PLoS ONE 8, e71794 (2013).","journal-title":"PLoS ONE"},{"key":"1129_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/ijms17121969","volume":"17","author":"P Goettig","year":"2016","unstructured":"Goettig, P. Effects of glycosylation on the enzymatic activity and mechanisms of proteases. Int. J. Mol. Sci. 17, 1969 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"1129_CR30","doi-asserted-by":"publisher","first-page":"41897","DOI":"10.1074\/jbc.M203097200","volume":"277","author":"JB Warner","year":"2002","unstructured":"Warner, J. B., Thalhauser, C., Tao, K. & Sahagian, G. G. Role of N-linked oligosaccharide flexibility in mannose phosphorylation of lysosomal enzyme cathepsin L. J. Biol. Chem. 277, 41897\u201341905 (2002).","journal-title":"J. Biol. Chem."},{"key":"1129_CR31","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1016\/j.febslet.2012.08.001","volume":"586","author":"Y Niwa","year":"2012","unstructured":"Niwa, Y., Suzuki, T., Dohmae, N., Umezawa, K. & Simizu, S. Determination of cathepsin V activity and intracellular trafficking by N-glycosylation. FEBS Lett. 586, 3601\u20133607 (2012).","journal-title":"FEBS Lett."},{"key":"1129_CR32","doi-asserted-by":"publisher","first-page":"15695","DOI":"10.1021\/bi001367j","volume":"39","author":"TS Mattu","year":"2000","unstructured":"Mattu, T. S. et al. O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. Biochemistry 39, 15695\u201315704 (2000).","journal-title":"Biochemistry"},{"key":"1129_CR33","doi-asserted-by":"publisher","first-page":"15249","DOI":"10.1021\/bi061254l","volume":"45","author":"SA Fry","year":"2006","unstructured":"Fry, S. A. et al. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3. Biochemistry 45, 15249\u201315258 (2006).","journal-title":"Biochemistry"},{"key":"1129_CR34","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","volume":"87","author":"HE Van Wart","year":"1990","unstructured":"Van Wart, H. E. & Birkedal-Hansen, H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl Acad. Sci. USA 87, 5578\u20135582 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1129_CR35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.yexcr.2012.02.021","volume":"318","author":"MM Khan","year":"2012","unstructured":"Khan, M. M. et al. Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9. Exp. Cell Res. 318, 904\u2013914 (2012).","journal-title":"Exp. Cell Res."},{"key":"1129_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","volume":"1824","author":"V Turk","year":"2012","unstructured":"Turk, V. et al. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta 1824, 68\u201388 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"1129_CR37","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.bcp.2003.08.002","volume":"66","author":"PD Sheth","year":"2003","unstructured":"Sheth, P. D., Pedersen, J., Walls, A. F. & McEuen, A. R. Inhibition of dipeptidyl peptidase I in the human mast cell line HMC-1: blocked activation of tryptase, but not of the predominant chymotryptic activity. Biochem. Pharmacol. 66, 2251\u20132262 (2003).","journal-title":"Biochem. Pharmacol."},{"key":"1129_CR38","doi-asserted-by":"publisher","first-page":"18551","DOI":"10.1074\/jbc.M100223200","volume":"276","author":"PJ Wolters","year":"2001","unstructured":"Wolters, P. J., Pham, C. T., Muilenburg, D. J., Ley, T. J. & Caughey, G. H. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J. Biol. Chem. 276, 18551\u201318556 (2001).","journal-title":"J. Biol. Chem."},{"key":"1129_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI0213462","volume":"109","author":"AM Adkison","year":"2002","unstructured":"Adkison, A. M., Raptis, S. Z., Kelley, D. G. & Pham, C. T. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest. 109, 363\u2013371 (2002).","journal-title":"J. Clin. Invest."},{"key":"1129_CR40","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1073\/pnas.96.15.8627","volume":"96","author":"CT Pham","year":"1999","unstructured":"Pham, C. T. & Ley, T. J. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl Acad. Sci. USA 96, 8627\u20138632 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1129_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/PG9.0000000000000138","volume":"2","author":"AU Freiburghaus","year":"2021","unstructured":"Freiburghaus, A. U., Roduner, J. & Hadorn, H. B. Activation of human pancreatic proteolytic enzymes: the role of enteropeptidase and trypsin. JPGN Rep. 2, e138 (2021).","journal-title":"JPGN Rep."},{"key":"1129_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.matbio.2015.03.004","volume":"44\u201346","author":"Y Itoh","year":"2015","unstructured":"Itoh, Y. Membrane-type matrix metalloproteinases: their functions and regulations. Matrix Biol. 44\u201346, 207\u2013223 (2015).","journal-title":"Matrix Biol."},{"key":"1129_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/bph.15985","volume":"180","author":"C Deraison","year":"2023","unstructured":"Deraison, C., Bonnart, C., Langella, P., Roget, K. & Vergnolle, N. Elafin and its precursor trappin-2: what is their therapeutic potential for intestinal diseases? Br. J. Pharmacol. 180, 144\u2013160 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR44","doi-asserted-by":"crossref","unstructured":"Deraison et al. in Inflammation Vol. 2 (eds Cavaillon, J. M. & Singer, M.) 727\u2013766 (Wiley, 2018).","DOI":"10.1002\/9783527692156.ch28"},{"key":"1129_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0167-7799(00)89013-7","volume":"13","author":"RA Engh","year":"1995","unstructured":"Engh, R. A., Huber, R., Bode, W. & Schulze, A. J. Divining the serpin inhibition mechanism: a suicide substrate \u2018springe\u2019? Trends Biotechnol. 13, 503\u2013510 (1995).","journal-title":"Trends Biotechnol."},{"key":"1129_CR46","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7224","volume":"7","author":"H Mkaouar","year":"2019","unstructured":"Mkaouar, H. et al. Serine protease inhibitors and human wellbeing interplay: new insights for old friends. PeerJ 7, e7224 (2019).","journal-title":"PeerJ"},{"key":"1129_CR47","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1093\/molbev\/msab081","volume":"38","author":"MA Spence","year":"2021","unstructured":"Spence, M. A., Mortimer, M. D., Buckle, A. M., Minh, B. Q. & Jackson, C. J. A comprehensive phylogenetic analysis of the serpin superfamily. Mol. Biol. Evol. 38, 2915\u20132929 (2021).","journal-title":"Mol. Biol. Evol."},{"key":"1129_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12934-016-0596-2","volume":"15","author":"H Mkaouar","year":"2016","unstructured":"Mkaouar, H. et al. Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases. Microb. Cell Fact. 15, 201 (2016).","journal-title":"Microb. Cell Fact."},{"key":"1129_CR49","doi-asserted-by":"publisher","first-page":"17246","DOI":"10.1074\/jbc.M601678200","volume":"281","author":"D Ivanov","year":"2006","unstructured":"Ivanov, D. et al. A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases. J. Biol. Chem. 281, 17246\u201317252 (2006).","journal-title":"J. Biol. Chem."},{"key":"1129_CR50","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1039\/C9CC03183A","volume":"55","author":"N Akermi","year":"2019","unstructured":"Akermi, N. et al. Para-sulphonato-calix[n]arene capped silver nanoparticles challenge the catalytic efficiency and the stability of a novel human gut serine protease inhibitor. Chem. Commun. 55, 8935\u20138938 (2019).","journal-title":"Chem. Commun."},{"key":"1129_CR51","doi-asserted-by":"publisher","first-page":"11032","DOI":"10.1016\/S0021-9258(17)44382-1","volume":"258","author":"CH Chung","year":"1983","unstructured":"Chung, C. H., Ives, H. E., Almeda, S. & Goldberg, A. L. Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases. J. Biol. Chem. 258, 11032\u201311038 (1983).","journal-title":"J. Biol. Chem."},{"key":"1129_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00430-016-0454-1","volume":"205","author":"M Kedzior","year":"2016","unstructured":"Kedzior, M., Seredynski, R. & Gutowicz, J. Microbial inhibitors of cysteine proteases. Med. Microbiol. Immunol. 205, 275\u2013296 (2016).","journal-title":"Med. Microbiol. Immunol."},{"key":"1129_CR53","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41586-022-05181-3","volume":"609","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Identification of trypsin-degrading commensals in the large intestine. Nature 609, 582\u2013589 (2022).","journal-title":"Nature"},{"key":"1129_CR54","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/MOG.0000000000000972","volume":"39","author":"S Rao","year":"2023","unstructured":"Rao, S. & Grover, M. Intestinal proteases. Curr. Opin. Gastroenterol. 39, 472\u2013478 (2023).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"1129_CR55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/00365529209165434","volume":"27","author":"EO Adeyemi","year":"1992","unstructured":"Adeyemi, E. O. & Hodgson, H. J. Faecal elastase reflects disease activity in active ulcerative colitis. Scand. J. Gastroenterol. 27, 139\u2013142 (1992).","journal-title":"Scand. J. Gastroenterol."},{"key":"1129_CR56","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/gutjnl-2012-304042","volume":"63","author":"D Tooth","year":"2014","unstructured":"Tooth, D. et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit. Gut 63, 753\u2013760 (2014).","journal-title":"Gut"},{"key":"1129_CR57","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41564-022-01103-1","volume":"7","author":"AL Edwinson","year":"2022","unstructured":"Edwinson, A. L. et al. Gut microbial beta-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome. Nat. Microbiol. 7, 680\u2013694 (2022).","journal-title":"Nat. Microbiol."},{"key":"1129_CR58","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1053\/j.gastro.2020.12.004","volume":"160","author":"HJ Galipeau","year":"2021","unstructured":"Galipeau, H. J. et al. Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. Gastroenterology 160, 1532\u20131545 (2021).","journal-title":"Gastroenterology"},{"key":"1129_CR59","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.1.e7","volume":"110","author":"J Walkowiak","year":"2002","unstructured":"Walkowiak, J., Herzig, K. H., Strzykala, K., Przyslawski, J. & Krawczynski, M. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 110, e7 (2002).","journal-title":"Pediatrics"},{"key":"1129_CR60","doi-asserted-by":"publisher","first-page":"167413","DOI":"10.1016\/j.jmb.2021.167413","volume":"434","author":"Y Arimura","year":"2022","unstructured":"Arimura, Y. & Funabiki, H. Structural mechanics of the alpha-2-macroglobulin transformation. J. Mol. Biol. 434, 167413 (2022).","journal-title":"J. Mol. Biol."},{"key":"1129_CR61","doi-asserted-by":"publisher","first-page":"48580","DOI":"10.1074\/jbc.M310301200","volume":"278","author":"R Szmola","year":"2003","unstructured":"Szmola, R., Kukor, Z. & Sahin-Toth, M. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J. Biol. Chem. 278, 48580\u201348589 (2003).","journal-title":"J. Biol. Chem."},{"key":"1129_CR62","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1074\/jbc.RA120.012526","volume":"295","author":"V Toldi","year":"2020","unstructured":"Toldi, V., Szabo, A. & Sahin-Toth, M. Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation. J. Biol. Chem. 295, 3447\u20133455 (2020).","journal-title":"J. Biol. Chem."},{"key":"1129_CR63","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/PL00000693","volume":"57","author":"LJ Hathaway","year":"2000","unstructured":"Hathaway, L. J. & Kraehenbuhl, J. P. The role of M cells in mucosal immunity. Cell. Mol. Life Sci. 57, 323\u2013332 (2000).","journal-title":"Cell. Mol. Life Sci."},{"key":"1129_CR64","first-page":"157","volume":"16","author":"EE Wheeler","year":"1993","unstructured":"Wheeler, E. E., Challacombe, D. N., Kerry, P. J. & Pearson, E. C. A morphological study of beta-lactoglobulin absorption by cultured explants of the human duodenal mucosa using immunocytochemical and cytochemical techniques. J. Pediatr. Gastroenterol. Nutr. 16, 157\u2013164 (1993).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"1129_CR65","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.biopha.2018.01.029","volume":"98","author":"RK Jaiswal","year":"2018","unstructured":"Jaiswal, R. K., Varshney, A. K. & Yadava, P. K. Diversity and functional evolution of the plasminogen activator system. Biomed. Pharmacother. 98, 886\u2013898 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"1129_CR66","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1021\/acs.biochem.0c00442","volume":"59","author":"AL Arai","year":"2020","unstructured":"Arai, A. L. et al. High-affinity binding of LDL receptor-related protein 1 to matrix metalloprotease 1 requires protease:inhibitor complex formation. Biochemistry 59, 2922\u20132933 (2020).","journal-title":"Biochemistry"},{"key":"1129_CR67","doi-asserted-by":"publisher","first-page":"107521","DOI":"10.1016\/j.jbc.2024.107521","volume":"300","author":"K Yamamoto","year":"2024","unstructured":"Yamamoto, K. et al. Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1. J. Biol. Chem. 300, 107521 (2024).","journal-title":"J. Biol. Chem."},{"key":"1129_CR68","unstructured":"Heda, R., Toro, F. & Tombazzi, C. R. Physiology, Pepsin. StatPearls [Internet] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537005\/ (updated 1 May 2024)."},{"key":"1129_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10620-006-9589-z","volume":"52","author":"DC Whitcomb","year":"2007","unstructured":"Whitcomb, D. C. & Lowe, M. E. Human pancreatic digestive enzymes. Dig. Dis. Sci. 52, 1\u201317 (2007).","journal-title":"Dig. Dis. Sci."},{"key":"1129_CR70","first-page":"G475","volume":"251","author":"P Layer","year":"1986","unstructured":"Layer, P., Go, V. L. & DiMagno, E. P. Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am. J. Physiol. 251, G475\u2013G480 (1986).","journal-title":"Am. J. Physiol."},{"key":"1129_CR71","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2249.2011.04523.x","volume":"167","author":"N Miron","year":"2012","unstructured":"Miron, N. & Cristea, V. Enterocytes: active cells in tolerance to food and microbial antigens in the gut. Clin. Exp. Immunol. 167, 405\u2013412 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"1129_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000082581","volume":"136","author":"K Takagi","year":"2005","unstructured":"Takagi, K. et al. Kinetic analysis of pepsin digestion of chicken egg white ovomucoid and allergenic potential of pepsin fragments. Int. Arch. Allergy Immunol. 136, 23\u201332 (2005).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"1129_CR73","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/all.12852","volume":"71","author":"BK Ballmer-Weber","year":"2016","unstructured":"Ballmer-Weber, B. K. et al. Hydrolysed egg displays strong decrease in allergenicity and is well tolerated by egg-allergic patients. Allergy 71, 728\u2013732 (2016).","journal-title":"Allergy"},{"key":"1129_CR74","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/cea.12989","volume":"47","author":"D Lozano-Ojalvo","year":"2017","unstructured":"Lozano-Ojalvo, D., Perez-Rodriguez, L., Pablos-Tanarro, A., Molina, E. & Lopez-Fandino, R. Hydrolysed ovalbumin offers more effective preventive and therapeutic protection against egg allergy than the intact protein. Clin. Exp. Allergy 47, 1342\u20131354 (2017).","journal-title":"Clin. Exp. Allergy"},{"key":"1129_CR75","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.alit.2022.03.006","volume":"71","author":"A Yamada","year":"2022","unstructured":"Yamada, A., Hasegawa, T., Fujieda, M., Morita, H. & Matsumoto, K. Protease-digested egg-white products induce oral tolerance in mice but elicit little IgE production upon epicutaneous exposure. Allergol. Int. 71, 528\u2013535 (2022).","journal-title":"Allergol. Int."},{"key":"1129_CR76","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2353\/ajpath.2006.051098","volume":"169","author":"F Cattaruzza","year":"2006","unstructured":"Cattaruzza, F. et al. Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia\/reperfusion in rodents. Am. J. Pathol. 169, 177\u2013188 (2006).","journal-title":"Am. J. Pathol."},{"key":"1129_CR77","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/gut.2004.048876","volume":"54","author":"N Vergnolle","year":"2005","unstructured":"Vergnolle, N. Clinical relevance of proteinase activated receptors (PARs) in the gut. Gut 54, 867\u2013874 (2005).","journal-title":"Gut"},{"key":"1129_CR78","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1152\/physrev.00044.2021","volume":"103","author":"CJ Peach","year":"2023","unstructured":"Peach, C. J., Edgington-Mitchell, L. E., Bunnett, N. W. & Schmidt, B. L. Protease-activated receptors in health and disease. Physiol. Rev. 103, 717\u2013785 (2023).","journal-title":"Physiol. Rev."},{"key":"1129_CR79","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1476-5381.1996.tb15433.x","volume":"118","author":"M Saifeddine","year":"1996","unstructured":"Saifeddine, M., al-Ani, B., Cheng, C. H., Wang, L. & Hollenberg, M. D. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br. J. Pharmacol. 118, 521\u2013530 (1996).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR80","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/S0016-5085(99)70180-0","volume":"116","author":"TM Cocks","year":"1999","unstructured":"Cocks, T. M., Sozzi, V., Moffatt, J. D. & Selemidis, S. Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle. Gastroenterology 116, 586\u2013592 (1999).","journal-title":"Gastroenterology"},{"key":"1129_CR81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/gut.2003.021899","volume":"53","author":"F Mule","year":"2004","unstructured":"Mule, F., Pizzuti, R., Capparelli, A. & Vergnolle, N. Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon. Gut 53, 229\u2013234 (2004).","journal-title":"Gut"},{"key":"1129_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14105","volume":"33","author":"A Annahazi","year":"2021","unstructured":"Annahazi, A., Schroder, A. & Schemann, M. Region-specific effects of the cysteine protease papain on gastric motility. Neurogastroenterol. Motil. 33, e14105 (2021).","journal-title":"Neurogastroenterol. Motil."},{"key":"1129_CR83","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2353\/ajpath.2009.090240","volume":"175","author":"K List","year":"2009","unstructured":"List, K. et al. Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. Am. J. Pathol. 175, 1453\u20131463 (2009).","journal-title":"Am. J. Pathol."},{"key":"1129_CR84","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1073\/pnas.0903923107","volume":"107","author":"MS Buzza","year":"2010","unstructured":"Buzza, M. S. et al. Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc. Natl Acad. Sci. USA 107, 4200\u20134205 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1129_CR85","doi-asserted-by":"publisher","first-page":"G466","DOI":"10.1152\/ajpgi.00441.2015","volume":"311","author":"NJ Ronaghan","year":"2016","unstructured":"Ronaghan, N. J. et al. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G466\u2013G479 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR86","doi-asserted-by":"publisher","first-page":"G60","DOI":"10.1152\/ajpgi.00096.2009","volume":"297","author":"VA Swystun","year":"2009","unstructured":"Swystun, V. A. et al. Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase Czeta. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G60\u2013G70 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR87","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ebiom.2018.05.031","volume":"33","author":"EEL Nystrom","year":"2018","unstructured":"Nystrom, E. E. L. et al. Calcium-activated chloride channel regulator 1 (CLCA1) controls mucus expansion in colon by proteolytic activity. EBioMedicine 33, 134\u2013143 (2018).","journal-title":"EBioMedicine"},{"key":"1129_CR88","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1369\/jhc.2010.955211","volume":"58","author":"E Roussa","year":"2010","unstructured":"Roussa, E. et al. Cellular distribution and subcellular localization of mCLCA1\/2 in murine gastrointestinal epithelia. J. Histochem. Cytochem. 58, 653\u2013668 (2010).","journal-title":"J. Histochem. Cytochem."},{"key":"1129_CR89","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0003-9861(88)90376-1","volume":"265","author":"EE Sterchi","year":"1988","unstructured":"Sterchi, E. E., Naim, H. Y., Lentze, M. J., Hauri, H. P. & Fransen, J. A. N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase: a metalloendopeptidase of the human intestinal microvillus membrane which degrades biologically active peptides. Arch. Biochem. Biophys. 265, 105\u2013118 (1988).","journal-title":"Arch. Biochem. Biophys."},{"key":"1129_CR90","doi-asserted-by":"publisher","first-page":"12396","DOI":"10.1073\/pnas.1407597111","volume":"111","author":"A Schutte","year":"2014","unstructured":"Schutte, A. et al. Microbial-induced meprin beta cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus. Proc. Natl Acad. Sci. USA 111, 12396\u201312401 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1129_CR91","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/j.celrep.2017.10.087","volume":"21","author":"R Wichert","year":"2017","unstructured":"Wichert, R. et al. Mucus detachment by host metalloprotease meprin beta requires shedding of its inactive pro-form, which is abrogated by the pathogenic protease RgpB. Cell Rep. 21, 2090\u20132103 (2017).","journal-title":"Cell Rep."},{"key":"1129_CR92","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1389450122666210809094100","volume":"23","author":"D Hammers","year":"2022","unstructured":"Hammers, D., Carothers, K. & Lee, S. The role of bacterial proteases in microbe and host\u2013microbe interactions. Curr. Drug Targets 23, 222\u2013239 (2022).","journal-title":"Curr. Drug Targets"},{"key":"1129_CR93","doi-asserted-by":"publisher","first-page":"1021094","DOI":"10.3389\/fimmu.2022.1021094","volume":"13","author":"M Pan","year":"2022","unstructured":"Pan, M., Barua, N. & Ip, M. Mucin-degrading gut commensals isolated from healthy faecal donor suppress intestinal epithelial inflammation and regulate tight junction barrier function. Front. Immunol. 13, 1021094 (2022).","journal-title":"Front. Immunol."},{"key":"1129_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001856","volume":"6","author":"SZ Hasnain","year":"2012","unstructured":"Hasnain, S. Z., McGuckin, M. A., Grencis, R. K. & Thornton, D. J. Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier. PLoS Negl. Trop. Dis. 6, e1856 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1129_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00427-y","volume":"9","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Strategy to combat biofilms: a focus on biofilm dispersal enzymes. npj Biofilms Microbiomes 9, 63 (2023).","journal-title":"npj Biofilms Microbiomes"},{"key":"1129_CR96","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.resmic.2009.08.017","volume":"160","author":"H Ingmer","year":"2009","unstructured":"Ingmer, H. & Brondsted, L. Proteases in bacterial pathogenesis. Res. Microbiol. 160, 704\u2013710 (2009).","journal-title":"Res. Microbiol."},{"key":"1129_CR97","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1053\/j.gastro.2016.06.041","volume":"151","author":"A Caminero","year":"2016","unstructured":"Caminero, A. et al. Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity. Gastroenterology 151, 670\u2013683 (2016).","journal-title":"Gastroenterology"},{"key":"1129_CR98","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1053\/j.gastro.2022.06.088","volume":"163","author":"M Constante","year":"2022","unstructured":"Constante, M. et al. Biogeographic variation and functional pathways of the gut microbiota in celiac disease. Gastroenterology 163, 1351\u20131363.e15 (2022).","journal-title":"Gastroenterology"},{"key":"1129_CR99","doi-asserted-by":"publisher","first-page":"G221","DOI":"10.1152\/ajpgi.00328.2015","volume":"311","author":"I Nasri","year":"2016","unstructured":"Nasri, I. et al. PAR2-dependent activation of GSK3beta regulates the survival of colon stem\/progenitor cells. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G221\u2013G236 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR100","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13293-019-0262-6","volume":"10","author":"J Noguerol","year":"2019","unstructured":"Noguerol, J. et al. Sexual dimorphism in PAR(2)-dependent regulation of primitive colonic cells. Biol. Sex Differ. 10, 47 (2019).","journal-title":"Biol. Sex Differ."},{"key":"1129_CR101","doi-asserted-by":"publisher","first-page":"G609","DOI":"10.1152\/ajpgi.00061.2022","volume":"323","author":"M Berger","year":"2022","unstructured":"Berger, M. et al. Prenatal stress induces changes in PAR2- and M3-dependent regulation of colon primitive cells. Am. J. Physiol. Gastrointest. Liver Physiol. 323, G609\u2013G626 (2022).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR102","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1111\/bph.14430","volume":"175","author":"M Sebert","year":"2018","unstructured":"Sebert, M. et al. Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1- and protease-activated receptor 4-dependent mechanism. Br. J. Pharmacol. 175, 3656\u20133668 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR103","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3748\/wjg.v23.i12.2106","volume":"23","author":"H Van Spaendonk","year":"2017","unstructured":"Van Spaendonk, H. et al. Regulation of intestinal permeability: the role of proteases. World J. Gastroenterol. 23, 2106\u20132123 (2017).","journal-title":"World J. Gastroenterol."},{"key":"1129_CR104","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/febs.15055","volume":"287","author":"G Pontarollo","year":"2020","unstructured":"Pontarollo, G. et al. Protease-activated receptor signaling in intestinal permeability regulation. FEBS J. 287, 645\u2013658 (2020).","journal-title":"FEBS J."},{"key":"1129_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.215","volume":"7","author":"F Souza-Fonseca-Guimaraes","year":"2016","unstructured":"Souza-Fonseca-Guimaraes, F. et al. Granzyme M has a critical role in providing innate immune protection in ulcerative colitis. Cell Death Dis. 7, e2302 (2016).","journal-title":"Cell Death Dis."},{"key":"1129_CR106","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.4049\/jimmunol.177.6.4103","volume":"177","author":"P Garg","year":"2006","unstructured":"Garg, P. et al. Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis. J. Immunol. 177, 4103\u20134112 (2006).","journal-title":"J. Immunol."},{"key":"1129_CR107","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41420-024-02015-1","volume":"10","author":"A Vilardi","year":"2024","unstructured":"Vilardi, A., Przyborski, S., Mobbs, C., Rufini, A. & Tufarelli, C. Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease. Cell Death Discov. 10, 258 (2024).","journal-title":"Cell Death Discov."},{"key":"1129_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fcimb.2020.00021","volume":"10","author":"A Jablaoui","year":"2020","unstructured":"Jablaoui, A. et al. Fecal serine protease profiling in inflammatory bowel diseases. Front. Cell. Infect. Microbiol. 10, 21 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1129_CR109","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1172\/JCI29255","volume":"117","author":"N Cenac","year":"2007","unstructured":"Cenac, N. et al. Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Invest. 117, 636\u2013647 (2007).","journal-title":"J. Clin. Invest."},{"key":"1129_CR110","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2353\/ajpath.2009.080986","volume":"175","author":"M Dabek","year":"2009","unstructured":"Dabek, M. et al. Luminal cathepsin G and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am. J. Pathol. 175, 207\u2013214 (2009).","journal-title":"Am. J. Pathol."},{"key":"1129_CR111","doi-asserted-by":"publisher","first-page":"fj201800560R","DOI":"10.1096\/fj.201800560R","volume":"32","author":"S Edogawa","year":"2018","unstructured":"Edogawa, S. et al. Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. FASEB J. 32, fj201800560R (2018).","journal-title":"FASEB J."},{"key":"1129_CR112","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/gut.2007.140210","volume":"57","author":"K Gecse","year":"2008","unstructured":"Gecse, K. et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 57, 591\u2013599 (2008).","journal-title":"Gut"},{"key":"1129_CR113","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/gut.2007.140806","volume":"58","author":"T Piche","year":"2009","unstructured":"Piche, T. et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58, 196\u2013201 (2009).","journal-title":"Gut"},{"key":"1129_CR114","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00004836-199901000-00002","volume":"28","author":"P Layer","year":"1999","unstructured":"Layer, P. & Keller, J. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease. J. Clin. Gastroenterol. 28, 3\u201310 (1999).","journal-title":"J. Clin. Gastroenterol."},{"key":"1129_CR115","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031141","volume":"101","author":"IM Larsen","year":"2022","unstructured":"Larsen, I. M. et al. Regional gastrointestinal transit times in patients with chronic pancreatitis. Medicine 101, e31141 (2022).","journal-title":"Medicine"},{"key":"1129_CR116","doi-asserted-by":"publisher","first-page":"158ra144","DOI":"10.1126\/scitranslmed.3004212","volume":"4","author":"JP Motta","year":"2012","unstructured":"Motta, J. P. et al. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl Med. 4, 158ra144 (2012).","journal-title":"Sci. Transl Med."},{"key":"1129_CR117","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI119658","volume":"100","author":"CU Corvera","year":"1997","unstructured":"Corvera, C. U. et al. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J. Clin. Invest. 100, 1383\u20131393 (1997).","journal-title":"J. Clin. Invest."},{"key":"1129_CR118","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.bjp.0704746","volume":"136","author":"F Mule","year":"2002","unstructured":"Mule, F., Baffi, M. C. & Cerra, M. C. Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br. J. Pharmacol. 136, 367\u2013374 (2002).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR119","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bjp.0702755","volume":"128","author":"A Kawabata","year":"1999","unstructured":"Kawabata, A., Kuroda, R., Nishikawa, H. & Kawai, K. Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation. Br. J. Pharmacol. 128, 865\u2013872 (1999).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR120","doi-asserted-by":"publisher","first-page":"G921","DOI":"10.1152\/ajpgi.00255.2018","volume":"315","author":"TS Sung","year":"2018","unstructured":"Sung, T. S. et al. The functional role of protease-activated receptors on contractile responses by activation of Ca2+ sensitization pathways in simian colonic muscles. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G921\u2013G931 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR121","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2982.2009.01380.x","volume":"22","author":"BS Chang","year":"2010","unstructured":"Chang, B. S., Chang, J. C. & Huang, S. C. Proteinase-activated receptors 1 and 2 mediate contraction of human oesophageal muscularis mucosae. Neurogastroenterol. Motil. 22, 93\u201397.e32 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"1129_CR122","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/89945","volume":"7","author":"N Vergnolle","year":"2001","unstructured":"Vergnolle, N. et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. 7, 821\u2013826 (2001).","journal-title":"Nat. Med."},{"key":"1129_CR123","doi-asserted-by":"publisher","first-page":"G81","DOI":"10.1152\/ajpgi.00221.2009","volume":"298","author":"F Cattaruzza","year":"2010","unstructured":"Cattaruzza, F. et al. Transient receptor potential ankyrin-1 has a major role in mediating visceral pain in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G81\u2013G91 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR124","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/j.gastro.2015.04.011","volume":"149","author":"N Cenac","year":"2015","unstructured":"Cenac, N. et al. Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome. Gastroenterology 149, 433\u201344.e7 (2015).","journal-title":"Gastroenterology"},{"key":"1129_CR125","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1136\/gutjnl-2016-312094","volume":"66","author":"C Rolland-Fourcade","year":"2017","unstructured":"Rolland-Fourcade, C. et al. Epithelial expression and function of trypsin-3 in irritable bowel syndrome. Gut 66, 1767\u20131778 (2017).","journal-title":"Gut"},{"key":"1129_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193943","volume":"13","author":"S Buhner","year":"2018","unstructured":"Buhner, S. et al. Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients. PLoS ONE 13, e0193943 (2018).","journal-title":"PLoS ONE"},{"key":"1129_CR127","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1053\/j.gastro.2011.07.035","volume":"141","author":"F Cattaruzza","year":"2011","unstructured":"Cattaruzza, F. et al. Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice. Gastroenterology 141, 1864\u20131874 (2011).","journal-title":"Gastroenterology"},{"key":"1129_CR128","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/sj.bjp.0704568","volume":"135","author":"S Asfaha","year":"2002","unstructured":"Asfaha, S., Brussee, V., Chapman, K., Zochodne, D. W. & Vergnolle, N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br. J. Pharmacol. 135, 1101\u20131106 (2002).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR129","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pain.2009.07.016","volume":"146","author":"L Martin","year":"2009","unstructured":"Martin, L. et al. Thrombin receptor: an endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain 146, 121\u2013129 (2009).","journal-title":"Pain"},{"key":"1129_CR130","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1097\/j.pain.0000000000001208","volume":"159","author":"C Desormeaux","year":"2018","unstructured":"Desormeaux, C. et al. Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons. Pain 159, 1257\u20131267 (2018).","journal-title":"Pain"},{"key":"1129_CR131","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1053\/j.gastro.2011.08.034","volume":"141","author":"K Mueller","year":"2011","unstructured":"Mueller, K. et al. Activity of protease-activated receptors in the human submucous plexus. Gastroenterology 141, 2088\u20132097.e1 (2011).","journal-title":"Gastroenterology"},{"key":"1129_CR132","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fnins.2012.00133","volume":"6","author":"EM Kugler","year":"2012","unstructured":"Kugler, E. M. et al. Activity of protease-activated receptors in primary cultured human myenteric neurons. Front. Neurosci. 6, 133 (2012).","journal-title":"Front. Neurosci."},{"key":"1129_CR133","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/sj.bjp.0706975","volume":"150","author":"S Asfaha","year":"2007","unstructured":"Asfaha, S. et al. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br. J. Pharmacol. 150, 176\u2013185 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR134","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/j.1365-2982.2009.01310.x","volume":"21","author":"C Auge","year":"2009","unstructured":"Auge, C., Balz-Hara, D., Steinhoff, M., Vergnolle, N. & Cenac, N. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol. Motil. 21, 1189-e107 (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"1129_CR135","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/j.1365-2982.2009.01353.x","volume":"21","author":"R Karanjia","year":"2009","unstructured":"Karanjia, R., Spreadbury, I., Bautista-Cruz, F., Tsang, M. E. & Vanner, S. Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol. Motil. 21, 1218\u20131221 (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"1129_CR136","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.devcel.2021.06.020","volume":"56","author":"JT O\u2019Connor","year":"2021","unstructured":"O\u2019Connor, J. T. et al. Proteolytic activation of growth-blocking peptides triggers calcium responses through the GPCR Mthl10 during epithelial wound detection. Dev. Cell 56, 2160\u20132175.e5 (2021).","journal-title":"Dev. Cell"},{"key":"1129_CR137","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/ecco-jcc\/jjad178","volume":"18","author":"C Biel","year":"2024","unstructured":"Biel, C., Faber, K. N., Bank, R. A. & Olinga, P. Matrix metalloproteinases in intestinal fibrosis. J. Crohns Colitis 18, 462\u2013478 (2024).","journal-title":"J. Crohns Colitis"},{"key":"1129_CR138","doi-asserted-by":"publisher","first-page":"2181922","DOI":"10.1080\/19490976.2023.2181922","volume":"15","author":"A Caminero","year":"2023","unstructured":"Caminero, A., Guzman, M., Libertucci, J. & Lomax, A. E. The emerging roles of bacterial proteases in intestinal diseases. Gut Microbes 15, 2181922 (2023).","journal-title":"Gut Microbes"},{"key":"1129_CR139","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1128\/IAI.01494-08","volume":"77","author":"SM Harrington","year":"2009","unstructured":"Harrington, S. M. et al. The pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect. Immun. 77, 2465\u20132473 (2009).","journal-title":"Infect. Immun."},{"key":"1129_CR140","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1053\/j.gastro.2011.05.035","volume":"141","author":"N Steck","year":"2011","unstructured":"Steck, N. et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141, 959\u2013971 (2011).","journal-title":"Gastroenterology"},{"key":"1129_CR141","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1128\/IAI.00425-15","volume":"83","author":"N Maharshak","year":"2015","unstructured":"Maharshak, N. et al. Enterococcus faecalis gelatinase mediates intestinal permeability via protease-activated receptor 2. Infect. Immun. 83, 2762\u20132770 (2015).","journal-title":"Infect. Immun."},{"key":"1129_CR142","doi-asserted-by":"publisher","first-page":"2387857","DOI":"10.1080\/19490976.2024.2387857","volume":"16","author":"LE Rondeau","year":"2024","unstructured":"Rondeau, L. E. et al. Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2. Gut Microbes 16, 2387857 (2024).","journal-title":"Gut Microbes"},{"key":"1129_CR143","doi-asserted-by":"publisher","first-page":"2205425","DOI":"10.1080\/19490976.2023.2205425","volume":"15","author":"A Santiago","year":"2023","unstructured":"Santiago, A. et al. Crohn\u2019s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice. Gut Microbes 15, 2205425 (2023).","journal-title":"Gut Microbes"},{"key":"1129_CR144","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/infdis\/jiv013","volume":"212","author":"AG Abreu","year":"2015","unstructured":"Abreu, A. G. et al. The serine protease pic from enteroaggregative Escherichia coli mediates immune evasion by the direct cleavage of complement proteins. J. Infect. Dis. 212, 106\u2013115 (2015).","journal-title":"J. Infect. Dis."},{"key":"1129_CR145","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1128\/IAI.00488-10","volume":"78","author":"D Orth","year":"2010","unstructured":"Orth, D. et al. EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3\/C3b and C5. Infect. Immun. 78, 4294\u20134301 (2010).","journal-title":"Infect. Immun."},{"key":"1129_CR146","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1128\/JB.182.14.4077-4086.2000","volume":"182","author":"T Guina","year":"2000","unstructured":"Guina, T., Yi, E. C., Wang, H., Hackett, M. & Miller, S. I. A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to alpha-helical antimicrobial peptides. J. Bacteriol. 182, 4077\u20134086 (2000).","journal-title":"J. Bacteriol."},{"key":"1129_CR147","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.915","volume":"8","author":"I Desloges","year":"2019","unstructured":"Desloges, I. et al. Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates. Microbiologyopen 8, e915 (2019).","journal-title":"Microbiologyopen"},{"key":"1129_CR148","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2958.2002.03146.x","volume":"46","author":"A Schmidtchen","year":"2002","unstructured":"Schmidtchen, A., Frick, I. M., Andersson, E., Tapper, H. & Bjorck, L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46, 157\u2013168 (2002).","journal-title":"Mol. Microbiol."},{"key":"1129_CR149","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1086\/432485","volume":"192","author":"RJ Edwards","year":"2005","unstructured":"Edwards, R. J. et al. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J. Infect. Dis. 192, 783\u2013790 (2005).","journal-title":"J. Infect. Dis."},{"key":"1129_CR150","doi-asserted-by":"publisher","first-page":"17864","DOI":"10.1073\/pnas.0904174106","volume":"106","author":"RJ Brezski","year":"2009","unstructured":"Brezski, R. J. et al. Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge. Proc. Natl Acad. Sci. USA 106, 17864\u201317869 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1129_CR151","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1128\/IAI.69.11.7187-7189.2001","volume":"69","author":"M Collin","year":"2001","unstructured":"Collin, M. & Olsen, A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect. Immun. 69, 7187\u20137189 (2001).","journal-title":"Infect. Immun."},{"key":"1129_CR152","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nsmb.2127","volume":"18","author":"U Eckhard","year":"2011","unstructured":"Eckhard, U., Schonauer, E., Nuss, D. & Brandstetter, H. Structure of collagenase G reveals a chew-and-digest mechanism of bacterial collagenolysis. Nat. Struct. Mol. Biol. 18, 1109\u20131114 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1129_CR153","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/ibd.21475","volume":"17","author":"M Pruteanu","year":"2011","unstructured":"Pruteanu, M., Hyland, N. P., Clarke, D. J., Kiely, B. & Shanahan, F. Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory bowel diseases. Inflamm. Bowel Dis. 17, 1189\u20131200 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"1129_CR154","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.3389\/fmicb.2019.02598","volume":"10","author":"CA Devaux","year":"2019","unstructured":"Devaux, C. A., Mezouar, S. & Mege, J. L. The E-cadherin cleavage associated to pathogenic bacteria infections can favor bacterial invasion and transmigration, dysregulation of the immune response and cancer induction in humans. Front. Microbiol. 10, 2598 (2019).","journal-title":"Front. Microbiol."},{"key":"1129_CR155","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1128\/iai.65.4.1431-1439.1997","volume":"65","author":"RJ Obiso Jr","year":"1997","unstructured":"Obiso, R. J. Jr, Azghani, A. O. & Wilkins, T. D. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect. Immun. 65, 1431\u20131439 (1997).","journal-title":"Infect. Immun."},{"key":"1129_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-017-0189-6","volume":"9","author":"A Harrer","year":"2017","unstructured":"Harrer, A., Boehm, M., Backert, S. & Tegtmeyer, N. Overexpression of serine protease HtrA enhances disruption of adherens junctions, paracellular transmigration and type IV secretion of CagA by Helicobacter pylori. Gut Pathog. 9, 40 (2017).","journal-title":"Gut Pathog."},{"key":"1129_CR157","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1165\/rcmb.2004-0274OC","volume":"32","author":"S Dulon","year":"2005","unstructured":"Dulon, S. et al. Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol. 32, 411\u2013419 (2005).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1129_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09037-9","volume":"10","author":"A Caminero","year":"2019","unstructured":"Caminero, A. et al. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat. Commun. 10, 1198 (2019).","journal-title":"Nat. Commun."},{"key":"1129_CR159","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2353\/ajpath.2006.050658","volume":"168","author":"M Holzhausen","year":"2006","unstructured":"Holzhausen, M. et al. Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection. Am. J. Pathol. 168, 1189\u20131199 (2006).","journal-title":"Am. J. Pathol."},{"key":"1129_CR160","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1016\/j.cell.2023.10.019","volume":"186","author":"L Deng","year":"2023","unstructured":"Deng, L. et al. S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis. Cell 186, 5375\u20135393.e25 (2023).","journal-title":"Cell"},{"key":"1129_CR161","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","volume":"7","author":"RH Mills","year":"2022","unstructured":"Mills, R. H. et al. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nat. Microbiol. 7, 262\u2013276 (2022).","journal-title":"Nat. Microbiol."},{"key":"1129_CR162","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jcmgh.2024.04.001","volume":"18","author":"X Li","year":"2024","unstructured":"Li, X. et al. Therapeutic effect of proteinase-activated receptor-1 antagonist on colitis-associated carcinogenesis. Cell. Mol. Gastroenterol. Hepatol. 18, 105\u2013131 (2024).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"1129_CR163","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ecco-jcc\/jjaa229","volume":"15","author":"JP Motta","year":"2021","unstructured":"Motta, J. P. et al. Increased mucosal thrombin is associated with Crohn\u2019s disease and causes inflammatory damage through protease-activated receptors activation. J. Crohns Colitis 15, 787\u2013799 (2021).","journal-title":"J. Crohns Colitis"},{"key":"1129_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26282-y","volume":"8","author":"A Denadai-Souza","year":"2018","unstructured":"Denadai-Souza, A. et al. Functional proteomic profiling of secreted serine proteases in health and inflammatory bowel disease. Sci. Rep. 8, 7834 (2018).","journal-title":"Sci. Rep."},{"key":"1129_CR165","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1021\/jm800180e","volume":"51","author":"S Chackalamannil","year":"2008","unstructured":"Chackalamannil, S. et al. Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J. Med. Chem. 51, 3061\u20133064 (2008).","journal-title":"J. Med. Chem."},{"key":"1129_CR166","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cts.12405","volume":"9","author":"WK Kraft","year":"2016","unstructured":"Kraft, W. K. et al. Effect of vorapaxar alone and in combination with aspirin on bleeding time and platelet aggregation in healthy adult subjects. Clin. Transl Sci. 9, 221\u2013227 (2016).","journal-title":"Clin. Transl Sci."},{"key":"1129_CR167","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1093\/ibd\/izab244","volume":"27","author":"JP Motta","year":"2021","unstructured":"Motta, J. P., Deraison, C., Le Grand, S., Le Grand, B. & Vergnolle, N. PAR-1 antagonism to promote gut mucosa healing in Crohn\u2019s disease patients: a new avenue for CVT120165. Inflamm. Bowel Dis. 27, S33\u2013S37 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"1129_CR168","doi-asserted-by":"publisher","first-page":"107883","DOI":"10.1016\/j.isci.2023.107883","volume":"26","author":"WH Yang","year":"2023","unstructured":"Yang, W. H. et al. Innate mechanism of mucosal barrier erosion in the pathogenesis of acquired colitis. iScience 26, 107883 (2023).","journal-title":"iScience"},{"key":"1129_CR169","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s005350070047","volume":"35","author":"T Kuwana","year":"2000","unstructured":"Kuwana, T. et al. Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis. J. Gastroenterol. 35, 682\u2013689 (2000).","journal-title":"J. Gastroenterol."},{"key":"1129_CR170","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10620-007-9840-2","volume":"53","author":"GR Lichtenstein","year":"2008","unstructured":"Lichtenstein, G. R. et al. Bowman\u2013Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis. Dig. Dis. Sci. 53, 175\u2013180 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"1129_CR171","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nbt840","volume":"21","author":"L Steidler","year":"2003","unstructured":"Steidler, L. et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21, 785\u2013789 (2003).","journal-title":"Nat. Biotechnol."},{"key":"1129_CR172","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","volume":"4","author":"H Braat","year":"2006","unstructured":"Braat, H. et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease. Clin. Gastroenterol. Hepatol. 4, 754\u2013759 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1129_CR173","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12602-023-10041-1","volume":"16","author":"GM Campos","year":"2024","unstructured":"Campos, G. M. et al. Lactococcus lactis as an interleukin delivery system for prophylaxis and treatment of inflammatory and autoimmune diseases. Probiot. Antimicrob. Proteins 16, 352\u2013366 (2024).","journal-title":"Probiot. Antimicrob. Proteins"},{"key":"1129_CR174","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12934-015-0198-4","volume":"14","author":"LG Bermudez-Humaran","year":"2015","unstructured":"Bermudez-Humaran, L. G. et al. Serine protease inhibitors protect better than IL-10 and TGF-beta anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci. Microb. Cell Fact. 14, 26 (2015).","journal-title":"Microb. Cell Fact."},{"key":"1129_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1574-6968.12159","volume":"344","author":"J Guy LeBlanc","year":"2013","unstructured":"Guy LeBlanc, J. et al. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol. Lett. 344, 1\u20139 (2013).","journal-title":"FEMS Microbiol. Lett."},{"key":"1129_CR176","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2147\/JIR.S288280","volume":"14","author":"M Maronek","year":"2021","unstructured":"Maronek, M. et al. Metalloproteinases in inflammatory bowel diseases. J. Inflamm. Res. 14, 1029\u20131041 (2021).","journal-title":"J. Inflamm. Res."},{"key":"1129_CR177","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/apt.13653","volume":"44","author":"WJ Sandborn","year":"2016","unstructured":"Sandborn, W. J. et al. Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis. Aliment. Pharmacol. Ther. 44, 157\u2013169 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1129_CR178","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ecco-jcc\/jjx180.021","volume":"12","author":"S Schreiber","year":"2018","unstructured":"Schreiber, S. et al. A phase 2, randomized, placebo-controlled study evaluating matrix metalloproteinase-9 inhibitor, andecaliximab, in patients with moderately to severely active Crohn\u2019s disease. J. Crohns Colitis 12, 1014\u20131020 (2018).","journal-title":"J. Crohns Colitis"},{"key":"1129_CR179","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1074\/jbc.M116.760579","volume":"292","author":"TC Appleby","year":"2017","unstructured":"Appleby, T. C. et al. Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9. J. Biol. Chem. 292, 6810\u20136820 (2017).","journal-title":"J. Biol. Chem."},{"key":"1129_CR180","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1053\/j.gastro.2015.07.002","volume":"149","author":"P Biancheri","year":"2015","unstructured":"Biancheri, P. et al. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease. Gastroenterology 149, 1564\u20131574.e3 (2015).","journal-title":"Gastroenterology"},{"key":"1129_CR181","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/br.2020.1300","volume":"13","author":"M Isabela Avila-Rodriguez","year":"2020","unstructured":"Isabela Avila-Rodriguez, M. et al. Practical context of enzymatic treatment for wound healing: a secreted protease approach (review). Biomed. Rep. 13, 3\u201314 (2020).","journal-title":"Biomed. Rep."},{"key":"1129_CR182","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41388-022-02583-5","volume":"42","author":"J Arai","year":"2023","unstructured":"Arai, J., Otoyama, Y., Nozawa, H., Kato, N. & Yoshida, H. The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review. Oncogene 42, 549\u2013558 (2023).","journal-title":"Oncogene"},{"key":"1129_CR183","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/molecules26040944","volume":"26","author":"M Calligaris","year":"2021","unstructured":"Calligaris, M. et al. Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution. Molecules 26, 944 (2021).","journal-title":"Molecules"},{"key":"1129_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024106","volume":"6","author":"I Cleynen","year":"2011","unstructured":"Cleynen, I. et al. Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. PLoS ONE 6, e24106 (2011).","journal-title":"PLoS ONE"},{"key":"1129_CR185","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/ecco-jcc\/jjaa033","volume":"14","author":"N Sola-Tapias","year":"2020","unstructured":"Sola-Tapias, N., Vergnolle, N., Denadai-Souza, A. & Barreau, F. The interplay between genetic risk factors and proteolytic dysregulation in the pathophysiology of inflammatory bowel disease. J. Crohns Colitis 14, 1149\u20131161 (2020).","journal-title":"J. Crohns Colitis"},{"key":"1129_CR186","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/ecco-jcc\/jjab035","volume":"15","author":"N Sola Tapias","year":"2021","unstructured":"Sola Tapias, N. et al. Colitis linked to endoplasmic reticulum stress induces trypsin activity affecting epithelial functions. J. Crohns Colitis 15, 1528\u20131541 (2021).","journal-title":"J. Crohns Colitis"},{"key":"1129_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0107-1","volume":"6","author":"D Knights","year":"2014","unstructured":"Knights, D. et al. Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med. 6, 107 (2014).","journal-title":"Genome Med."},{"key":"1129_CR188","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","volume":"67","author":"F Imhann","year":"2018","unstructured":"Imhann, F. et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67, 108\u2013119 (2018).","journal-title":"Gut"},{"key":"1129_CR189","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/apt.17718","volume":"58","author":"LM Janssen","year":"2023","unstructured":"Janssen, L. M. et al. Abdominal pain in patients with inflammatory bowel disease in remission: a prospective study on contributing factors. Aliment. Pharmacol. Ther. 58, 1041\u20131051 (2023).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1129_CR190","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara, G. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693\u2013702 (2004).","journal-title":"Gastroenterology"},{"key":"1129_CR191","doi-asserted-by":"publisher","first-page":"603","DOI":"10.14309\/ajg.0000000000003042","volume":"120","author":"R Quan","year":"2025","unstructured":"Quan, R. et al. Fecal Proteolytic bacteria and Staphylococcal superantigens are associated with abdominal pain severity in irritable bowel syndrome. Am. J. Gastroenterol. 120, 603\u2013613 (2025).","journal-title":"Am. J. Gastroenterol."},{"key":"1129_CR192","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1365-2982.2008.01155.x","volume":"20","author":"R Roka","year":"2008","unstructured":"Roka, R., Wittmann, T. & Bueno, L. Altered protease signalling in the gut: a novel pathophysiological factor in irritable bowel syndrome. Neurogastroenterol. Motil. 20, 853\u2013856 (2008).","journal-title":"Neurogastroenterol. Motil."},{"key":"1129_CR193","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1111\/bph.14396","volume":"175","author":"H Ceuleers","year":"2018","unstructured":"Ceuleers, H. et al. Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome. Br. J. Pharmacol. 175, 3516\u20133533 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR194","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1111\/bph.70100","volume":"182","author":"M David","year":"2025","unstructured":"David, M. et al. Bispecific nanobody as a new pharmacological drug for the selective inhibition of trypsin-3. Br. J. Pharmacol. 182, 4578\u20134591 (2025).","journal-title":"Br. J. Pharmacol."},{"key":"1129_CR195","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","volume":"590","author":"J Aguilera-Lizarraga","year":"2021","unstructured":"Aguilera-Lizarraga, J. et al. Local immune response to food antigens drives meal-induced abdominal pain. Nature 590, 151\u2013156 (2021).","journal-title":"Nature"},{"key":"1129_CR196","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1053\/j.gastro.2022.07.071","volume":"163","author":"JA Murray","year":"2022","unstructured":"Murray, J. A. et al. Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge. Gastroenterology 163, 1510\u20131521.e6 (2022).","journal-title":"Gastroenterology"},{"key":"1129_CR197","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1021\/jacs.5b08325","volume":"137","author":"C Wolf","year":"2015","unstructured":"Wolf, C. et al. Engineering of Kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions. J. Am. Chem. Soc. 137, 13106\u201313113 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"1129_CR198","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.gastro.2024.02.050","volume":"167","author":"V Discepolo","year":"2024","unstructured":"Discepolo, V., Kelly, C. P., Koning, F. & Schuppan, D. How future pharmacologic therapies for celiac disease will complement the gluten-free diet. Gastroenterology 167, 90\u2013103 (2024).","journal-title":"Gastroenterology"},{"key":"1129_CR199","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/ajg.2014.48","volume":"109","author":"HJ Galipeau","year":"2014","unstructured":"Galipeau, H. J. et al. Novel role of the serine protease inhibitor elafin in gluten-related disorders. Am. J. Gastroenterol. 109, 748\u2013756 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"1129_CR200","doi-asserted-by":"publisher","first-page":"e01323","DOI":"10.1128\/AEM.01323-17","volume":"83","author":"JL McCarville","year":"2017","unstructured":"McCarville, J. L. et al. A commensal Bifidobacterium longum strain prevents gluten-related immunopathology in mice through expression of a serine protease inhibitor. Appl. Environ. Microbiol. 83, e01323-17 (2017).","journal-title":"Appl. Environ. Microbiol."},{"key":"1129_CR201","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1017\/S0007114514000609","volume":"112","author":"M Olivares","year":"2014","unstructured":"Olivares, M., Castillejo, G., Varea, V. & Sanz, Y. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br. J. Nutr. 112, 30\u201340 (2014).","journal-title":"Br. J. Nutr."},{"key":"1129_CR202","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1053\/j.gastro.2019.02.028","volume":"156","author":"A Caminero","year":"2019","unstructured":"Caminero, A. et al. Lactobacilli degrade wheat amylase trypsin inhibitors to reduce intestinal dysfunction induced by immunogenic wheat proteins. Gastroenterology 156, 2266\u20132280 (2019).","journal-title":"Gastroenterology"},{"key":"1129_CR203","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21315\/mjms2020.27.4.2","volume":"27","author":"WT Cheng","year":"2020","unstructured":"Cheng, W. T., Kantilal, H. K. & Davamani, F. The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation. Malays. J. Med. Sci. 27, 9\u201321 (2020).","journal-title":"Malays. J. Med. Sci."},{"key":"1129_CR204","doi-asserted-by":"publisher","first-page":"107347","DOI":"10.1016\/j.jbc.2024.107347","volume":"300","author":"ES Radisky","year":"2024","unstructured":"Radisky, E. S. Extracellular proteolysis in cancer: proteases, substrates, and mechanisms in tumor progression and metastasis. J. Biol. Chem. 300, 107347 (2024).","journal-title":"J. Biol. Chem."},{"key":"1129_CR205","doi-asserted-by":"publisher","first-page":"643645","DOI":"10.1155\/2014\/643645","volume":"2014","author":"M Matusiewicz","year":"2014","unstructured":"Matusiewicz, M., Neubauer, K., Mierzchala-Pasierb, M., Gamian, A. & Krzystek-Korpacka, M. Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases. Dis. Markers 2014, 643645 (2014).","journal-title":"Dis. Markers"},{"key":"1129_CR206","doi-asserted-by":"publisher","first-page":"103","DOI":"10.17219\/acem\/37031","volume":"23","author":"A Kofla-Dlubacz","year":"2014","unstructured":"Kofla-Dlubacz, A., Matusiewicz, M., Krzesiek, E., Noga, L. & Iwanczak, B. Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children. Adv. Clin. Exp. Med. 23, 103\u2013110 (2014).","journal-title":"Adv. Clin. Exp. Med."},{"key":"1129_CR207","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3109\/00365521.2012.677954","volume":"47","author":"L Makitalo","year":"2012","unstructured":"Makitalo, L., Rintamaki, H., Tervahartiala, T., Sorsa, T. & Kolho, K. L. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-\u03b1 therapy in pediatric inflammatory bowel disease. Scand. J. Gastroenterol. 47, 785\u2013794 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"1129_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32988-5","volume":"13","author":"AP Amini","year":"2022","unstructured":"Amini, A. P. et al. Multiscale profiling of protease activity in cancer. Nat. Commun. 13, 5745 (2022).","journal-title":"Nat. Commun."},{"key":"1129_CR209","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cell.2020.01.003","volume":"180","author":"HR Maun","year":"2020","unstructured":"Maun, H. R. et al. An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma. Cell 180, 406 (2020).","journal-title":"Cell"},{"key":"1129_CR210","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/gut.24.8.718","volume":"24","author":"U Karbach","year":"1983","unstructured":"Karbach, U., Ewe, K. & Bodenstein, H. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn\u2019s disease. Gut 24, 718\u2013723 (1983).","journal-title":"Gut"},{"key":"1129_CR211","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3390\/diagnostics11122371","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Wang, W., Zhu, S. & Chen, Y. Increased SERPINA3 level is associated with ulcerative colitis. Diagnostics 11, 2371 (2021).","journal-title":"Diagnostics"},{"key":"1129_CR212","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1023\/A:1022569623350","volume":"48","author":"A Stadnicki","year":"2003","unstructured":"Stadnicki, A. et al. Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease. Dig. Dis. Sci. 48, 615\u2013623 (2003).","journal-title":"Dig. Dis. Sci."},{"key":"1129_CR213","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41575-019-0139-5","volume":"16","author":"K Ray","year":"2019","unstructured":"Ray, K. Coagulation and IBD \u2014 PAI1 provides the missing link. Nat. Rev. Gastroenterol. Hepatol. 16, 261 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1129_CR214","doi-asserted-by":"publisher","first-page":"eaat0852","DOI":"10.1126\/scitranslmed.aat0852","volume":"11","author":"GE Kaiko","year":"2019","unstructured":"Kaiko, G. E. et al. PAI-1 augments mucosal damage in colitis. Sci. Transl Med. 11, eaat0852 (2019).","journal-title":"Sci. Transl Med."},{"key":"1129_CR215","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1189\/jlb.0906581","volume":"81","author":"M Schmid","year":"2007","unstructured":"Schmid, M. et al. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn\u2019s disease. J. Leukoc. Biol. 81, 907\u2013915 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"1129_CR216","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/MIB.0000000000001252","volume":"23","author":"W Zhang","year":"2017","unstructured":"Zhang, W., Teng, G., Wu, T., Tian, Y. & Wang, H. Expression and clinical significance of elafin in inflammatory bowel disease. Inflamm. Bowel Dis. 23, 2134\u20132141 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"1129_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.120","volume":"5","author":"T Athwal","year":"2014","unstructured":"Athwal, T. et al. Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death. Cell Death Dis. 5, e1165 (2014).","journal-title":"Cell Death Dis."},{"key":"1129_CR218","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00251-007-0199-5","volume":"59","author":"MC Wapenaar","year":"2007","unstructured":"Wapenaar, M. C. et al. The SPINK gene family and celiac disease susceptibility. Immunogenetics 59, 349\u2013357 (2007).","journal-title":"Immunogenetics"},{"key":"1129_CR219","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/0002-9610(84)90052-7","volume":"147","author":"MJ McMahon","year":"1984","unstructured":"McMahon, M. J., Bowen, M., Mayer, A. D. & Cooper, E. H. Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am. J. Surg. 147, 164\u2013170 (1984).","journal-title":"Am. J. Surg."},{"key":"1129_CR220","first-page":"597","volume":"37","author":"K Becker","year":"1999","unstructured":"Becker, K., Niederau, C. & Frieling, T. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease. Z. Gastroenterol. 37, 597\u2013605 (1999).","journal-title":"Z. Gastroenterol."},{"key":"1129_CR221","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gut.47.1.57","volume":"47","author":"RB Heuschkel","year":"2000","unstructured":"Heuschkel, R. B. et al. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut 47, 57\u201362 (2000).","journal-title":"Gut"},{"key":"1129_CR222","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/gut.44.1.17","volume":"44","author":"S Daum","year":"1999","unstructured":"Daum, S. et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44, 17\u201325 (1999).","journal-title":"Gut"},{"key":"1129_CR223","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1053\/j.gastro.2012.07.016","volume":"143","author":"I Monteleone","year":"2012","unstructured":"Monteleone, I. et al. Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine. Gastroenterology 143, 1277\u20131287.e4 (2012).","journal-title":"Gastroenterology"},{"key":"1129_CR224","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-230X-8-55","volume":"8","author":"AN Kapsoritakis","year":"2008","unstructured":"Kapsoritakis, A. N. et al. Imbalance of tissue inhibitors of metalloproteinases (TIMP)-1 and -4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol. 8, 55 (2008).","journal-title":"BMC Gastroenterol."},{"key":"1129_CR225","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.bbrc.2009.12.022","volume":"391","author":"X Chen","year":"2010","unstructured":"Chen, X. et al. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation. Biochem. Biophys. Res. Commun. 391, 1070\u20131074 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1129_CR226","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3390\/cancers13081877","volume":"13","author":"G Lalmanach","year":"2021","unstructured":"Lalmanach, G., Kasabova-Arjomand, M., Lecaille, F. & Saidi, A. Cystatin M\/E (cystatin 6): a Janus-faced cysteine protease inhibitor with both tumor-suppressing and tumor-promoting functions. Cancers 13, 1877 (2021).","journal-title":"Cancers"},{"key":"1129_CR227","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ibd\/izae194","volume":"31","author":"YK Jun","year":"2025","unstructured":"Jun, Y. K. et al. The potential of molecular remission: tissue neutrophil elastase is better than histological activity for predicting long-term relapse in patients with ulcerative colitis in endoscopic remission. Inflamm. Bowel Dis. 31, 514\u2013523 (2025).","journal-title":"Inflamm. Bowel Dis."},{"key":"1129_CR228","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcmgh.2021.03.002","volume":"12","author":"B Drury","year":"2021","unstructured":"Drury, B., Hardisty, G., Gray, R. D. & Ho, G. T. Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation. Cell Mol. Gastroenterol. Hepatol. 12, 321\u2013333 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1129_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49840-4","volume":"9","author":"BM Anderson","year":"2019","unstructured":"Anderson, B. M. et al. Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease. Sci. Rep. 9, 13295 (2019).","journal-title":"Sci. Rep."},{"key":"1129_CR230","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/ibd\/izaa125","volume":"27","author":"B Liu","year":"2021","unstructured":"Liu, B. et al. Mast cell tryptase promotes inflammatory bowel disease-induced intestinal fibrosis. Inflamm. Bowel Dis. 27, 242\u2013255 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"1129_CR231","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3390\/ijms20143400","volume":"20","author":"B Frossi","year":"2019","unstructured":"Frossi, B., De Carli, M. & Calabro, A. Coeliac disease and mast cells. Int. J. Mol. Sci. 20, 3400 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1129_CR232","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1074\/jbc.M116.771469","volume":"292","author":"MS Buzza","year":"2017","unstructured":"Buzza, M. S. et al. Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis. J. Biol. Chem. 292, 10801\u201310812 (2017).","journal-title":"J. Biol. Chem."},{"key":"1129_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44454-3","volume":"13","author":"S Soussou","year":"2023","unstructured":"Soussou, S. et al. Serine proteases and metalloproteases are highly increased in irritable bowel syndrome Tunisian patients. Sci. Rep. 13, 17571 (2023).","journal-title":"Sci. Rep."},{"key":"1129_CR234","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2249.2006.03188.x","volume":"146","author":"K Menzel","year":"2006","unstructured":"Menzel, K. et al. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin. Exp. Immunol. 146, 169\u2013180 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"1129_CR235","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/ecco-jcc\/jjac110","volume":"17","author":"R Vitali","year":"2023","unstructured":"Vitali, R. et al. Proteomic analysis identifies three reliable biomarkers of intestinal inflammation in the stools of patients with inflammatory bowel disease. J. Crohns Colitis 17, 92\u2013102 (2023).","journal-title":"J. Crohns Colitis"},{"key":"1129_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06554","volume":"7","author":"K Okada","year":"2021","unstructured":"Okada, K., Itoh, H. & Ikemoto, M. Serum complement C3 and \u03b12-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients. Heliyon 7, e06554 (2021).","journal-title":"Heliyon"},{"key":"1129_CR237","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.4049\/jimmunol.1300972","volume":"191","author":"Z Huang","year":"2013","unstructured":"Huang, Z. et al. Calpastatin prevents NF-kappaB-mediated hyperactivation of macrophages and attenuates colitis. J. Immunol. 191, 3778\u20133788 (2013).","journal-title":"J. Immunol."},{"key":"1129_CR238","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/gutjnl-2011-301213","volume":"62","author":"C Swan","year":"2013","unstructured":"Swan, C. et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNF\u03b1. Gut 62, 985\u2013994 (2013).","journal-title":"Gut"},{"key":"1129_CR239","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1172\/JCI43792","volume":"121","author":"I Lerner","year":"2011","unstructured":"Lerner, I. et al. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. J. Clin. Invest. 121, 1709\u20131721 (2011).","journal-title":"J. Clin. Invest."},{"key":"1129_CR240","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0016-5085(99)70339-2","volume":"117","author":"MD Baugh","year":"1999","unstructured":"Baugh, M. D. et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 117, 814\u2013822 (1999).","journal-title":"Gastroenterology"},{"key":"1129_CR241","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/labinvest.3700225","volume":"85","author":"R Ciccocioppo","year":"2005","unstructured":"Ciccocioppo, R. et al. Matrix metalloproteinase pattern in celiac duodenal mucosa. Lab Invest. 85, 397\u2013407 (2005).","journal-title":"Lab Invest."},{"key":"1129_CR242","doi-asserted-by":"publisher","first-page":"1020902","DOI":"10.3389\/fimmu.2022.1020902","volume":"13","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y. et al. Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein claudin-7. Front. Immunol. 13, 1020902 (2022).","journal-title":"Front. Immunol."},{"key":"1129_CR243","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/gutjnl-2012-303252","volume":"63","author":"PJ Koelink","year":"2014","unstructured":"Koelink, P. J. et al. Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease. Gut 63, 578\u2013587 (2014).","journal-title":"Gut"},{"key":"1129_CR244","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/01.mib.0000234133.97594.04","volume":"12","author":"T Rath","year":"2006","unstructured":"Rath, T. et al. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential? Inflamm. Bowel Dis. 12, 1025\u20131035 (2006).","journal-title":"Inflamm. Bowel Dis."},{"key":"1129_CR245","doi-asserted-by":"publisher","first-page":"1163198","DOI":"10.3389\/fimmu.2023.1163198","volume":"14","author":"K Koop","year":"2023","unstructured":"Koop, K. et al. Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis. Front. Immunol. 14, 1163198 (2023).","journal-title":"Front. Immunol."},{"key":"1129_CR246","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/MIB.0b013e31828028e8","volume":"19","author":"E Franze","year":"2013","unstructured":"Franze, E. et al. High expression of the \u2018A Disintegrin and Metalloprotease\u2019 19 (ADAM19), a sheddase for TNF-\u03b1 in the mucosa of patients with inflammatory bowel diseases. Inflamm. Bowel Dis. 19, 501\u2013511 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"1129_CR247","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ebiom.2016.02.007","volume":"5","author":"M Shimoda","year":"2016","unstructured":"Shimoda, M. et al. Epithelial cell-derived a disintegrin and metalloproteinase-17 confers resistance to colonic inflammation through EGFR activation. EBioMedicine 5, 114\u2013124 (2016).","journal-title":"EBioMedicine"},{"key":"1129_CR248","doi-asserted-by":"publisher","first-page":"G1332","DOI":"10.1152\/ajpgi.90641.2008","volume":"296","author":"A Cesaro","year":"2009","unstructured":"Cesaro, A. et al. Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1332\u2013G1343 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1129_CR249","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/gut.51.1.37","volume":"51","author":"J Brynskov","year":"2002","unstructured":"Brynskov, J. et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 51, 37\u201343 (2002).","journal-title":"Gut"},{"key":"1129_CR250","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/BF01318124","volume":"31","author":"H Rinderknecht","year":"1986","unstructured":"Rinderknecht, H. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig. Dis. Sci. 31, 314\u2013321 (1986).","journal-title":"Dig. Dis. Sci."},{"key":"1129_CR251","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcmgh.2018.05.008","volume":"6","author":"H Yoon","year":"2018","unstructured":"Yoon, H. et al. Increased pancreatic protease activity in response to antibiotics impairs gut barrier and triggers colitis. Cell Mol. Gastroenterol. Hepatol. 6, 370\u2013388.e3 (2018).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1129_CR252","unstructured":"Schmitz, J. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management (eds Walker, W. A. et al.) 8\u201320 (PMPH-USA, 2004)."},{"key":"1129_CR253","doi-asserted-by":"publisher","first-page":"13532","DOI":"10.1074\/jbc.M312090200","volume":"279","author":"GS Cottrell","year":"2004","unstructured":"Cottrell, G. S., Amadesi, S., Grady, E. F. & Bunnett, N. W. Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J. Biol. Chem. 279, 13532\u201313539 (2004).","journal-title":"J. Biol. Chem."},{"key":"1129_CR254","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni797","volume":"3","author":"D Ghosh","year":"2002","unstructured":"Ghosh, D. et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3, 583\u2013590 (2002).","journal-title":"Nat. Immunol."},{"key":"1129_CR255","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1158\/0008-5472.CAN-18-1745","volume":"79","author":"NR Pawar","year":"2019","unstructured":"Pawar, N. R., Buzza, M. S. & Antalis, T. M. Membrane-anchored serine proteases and protease-activated receptor-2-mediated signaling: co-conspirators in cancer progression. Cancer Res. 79, 301\u2013310 (2019).","journal-title":"Cancer Res."},{"key":"1129_CR256","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1021\/acschembio.9b00608","volume":"14","author":"MH Gordon","year":"2019","unstructured":"Gordon, M. H. et al. N-terminomics\/TAILS profiling of proteases and their substrates in ulcerative colitis. ACS Chem. Biol. 14, 2471\u20132483 (2019).","journal-title":"ACS Chem. Biol."},{"key":"1129_CR257","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ddmod.2011.06.004","volume":"8","author":"H Dai","year":"2011","unstructured":"Dai, H. & Korthuis, R. J. Mast cell proteases and inflammation. Drug Discov. Today Dis. Model. 8, 47\u201355 (2011).","journal-title":"Drug Discov. Today Dis. Model."},{"key":"1129_CR258","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0065-2776(07)95006-3","volume":"95","author":"G Pejler","year":"2007","unstructured":"Pejler, G., Abrink, M., Ringvall, M. & Wernersson, S. Mast cell proteases. Adv. Immunol. 95, 167\u2013255 (2007).","journal-title":"Adv. Immunol."},{"key":"1129_CR259","doi-asserted-by":"publisher","first-page":"924866","DOI":"10.3389\/fimmu.2022.924866","volume":"13","author":"N Chalkidi","year":"2022","unstructured":"Chalkidi, N., Paraskeva, C. & Koliaraki, V. Fibroblasts in intestinal homeostasis, damage, and repair. Front. Immunol. 13, 924866 (2022).","journal-title":"Front. Immunol."},{"key":"1129_CR260","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/gut.2003.017442","volume":"53","author":"T Kirkegaard","year":"2004","unstructured":"Kirkegaard, T., Hansen, A., Bruun, E. & Brynskov, J. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn\u2019s disease. Gut 53, 701\u2013709 (2004).","journal-title":"Gut"},{"key":"1129_CR261","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714\u2013730.e22 (2019).","journal-title":"Cell"},{"key":"1129_CR262","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.intimp.2003.12.010","volume":"4","author":"LP Hale","year":"2004","unstructured":"Hale, L. P. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int. Immunopharmacol. 4, 255\u2013264 (2004).","journal-title":"Int. Immunopharmacol."},{"key":"1129_CR263","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1039\/C5FO00454C","volume":"6","author":"E Cruz-Huerta","year":"2015","unstructured":"Cruz-Huerta, E. et al. The protective role of the Bowman\u2013Birk protease inhibitor in soybean lunasin digestion: the effect of released peptides on colon cancer growth. Food Funct. 6, 2626\u20132635 (2015).","journal-title":"Food Funct."},{"key":"1129_CR264","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/DMSO.S201853","volume":"13","author":"M Flechtner-Mors","year":"2020","unstructured":"Flechtner-Mors, M. et al. The effect of potato protease inhibitor II on gastrointestinal hormones and satiety in humans during weight reduction. Diabetes Metab. Syndr. Obes. 13, 521\u2013534 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"1129_CR265","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.biocel.2007.11.008","volume":"40","author":"CT Pham","year":"2008","unstructured":"Pham, C. T. Neutrophil serine proteases fine-tune the inflammatory response. Int. J. Biochem. Cell Biol. 40, 1317\u20131333 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1129_CR266","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1002\/eji.201141538","volume":"41","author":"C Verollet","year":"2011","unstructured":"Verollet, C. et al. Extracellular proteolysis in macrophage migration: losing grip for a breakthrough. Eur. J. Immunol. 41, 2805\u20132813 (2011).","journal-title":"Eur. J. Immunol."},{"key":"1129_CR267","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0009-8981(99)00227-2","volume":"291","author":"L Herszenyi","year":"2000","unstructured":"Herszenyi, L. et al. Proteases in gastrointestinal neoplastic diseases. Clin. Chim. Acta 291, 171\u2013187 (2000).","journal-title":"Clin. Chim. Acta"},{"key":"1129_CR268","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.1277","volume":"199","author":"H Yamamoto","year":"2003","unstructured":"Yamamoto, H. et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J. Pathol. 199, 176\u2013184 (2003).","journal-title":"J. Pathol."},{"key":"1129_CR269","doi-asserted-by":"publisher","first-page":"32592","DOI":"10.18632\/oncotarget.8693","volume":"7","author":"Y Xie","year":"2016","unstructured":"Xie, Y. et al. The levels of serine proteases in colon tissue interstitial fluid and serum serve as an indicator of colorectal cancer progression. Oncotarget 7, 32592\u201332606 (2016).","journal-title":"Oncotarget"},{"key":"1129_CR270","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/cs0780265","volume":"78","author":"DA Hutton","year":"1990","unstructured":"Hutton, D. A., Pearson, J. P., Allen, A. & Foster, S. N. Mucolysis of the colonic mucus barrier by faecal proteinases: inhibition by interacting polyacrylate. Clin. Sci. 78, 265\u2013271 (1990).","journal-title":"Clin. Sci."},{"key":"1129_CR271","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1042\/bst0151074","volume":"15","author":"DA Hutton","year":"1987","unstructured":"Hutton, D. A., Allen, A., Cunliffe, W. J. & Pearson, J. P. Proteolytic degradation of mucus in the colon. Biochem. Soc. Trans. 15, 1074 (1987).","journal-title":"Biochem. Soc. Trans."},{"key":"1129_CR272","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1242\/jcs.114.1.111","volume":"114","author":"V Noe","year":"2001","unstructured":"Noe, V. et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 114, 111\u2013118 (2001).","journal-title":"J. Cell Sci."},{"key":"1129_CR273","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.coph.2004.08.004","volume":"4","author":"S Amadesi","year":"2004","unstructured":"Amadesi, S. & Bunnett, N. Protease-activated receptors: protease signaling in the gastrointestinal tract. Curr. Opin. Pharmacol. 4, 551\u2013556 (2004).","journal-title":"Curr. Opin. Pharmacol."},{"key":"1129_CR274","doi-asserted-by":"publisher","first-page":"11104","DOI":"10.1073\/pnas.1831452100","volume":"100","author":"A Chin","year":"2003","unstructured":"Chin, A. et al. Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc. Natl Acad. Sci. USA 100, 11104\u201311109 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1129_CR275","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.4049\/jimmunol.181.8.5702","volume":"181","author":"AC Chin","year":"2008","unstructured":"Chin, A. C., Lee, W. Y., Nusrat, A., Vergnolle, N. & Parkos, C. A. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J. Immunol. 181, 5702\u20135710 (2008).","journal-title":"J. Immunol."},{"key":"1129_CR276","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0002-9440(10)64466-5","volume":"161","author":"N Cenac","year":"2002","unstructured":"Cenac, N. et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161, 1903\u20131915 (2002).","journal-title":"Am. J. Pathol."},{"key":"1129_CR277","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1113\/jphysiol.2004.061721","volume":"558","author":"N Cenac","year":"2004","unstructured":"Cenac, N. et al. PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. J. Physiol. 558, 913\u2013925 (2004).","journal-title":"J. Physiol."},{"key":"1129_CR278","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/cells11050878","volume":"11","author":"Y Kim","year":"2022","unstructured":"Kim, Y. et al. Modulation of intestinal epithelial permeability via protease-activated receptor-2-induced autophagy. Cells 11, 878 (2022).","journal-title":"Cells"},{"key":"1129_CR279","doi-asserted-by":"publisher","first-page":"C113","DOI":"10.1152\/ajpcell.00162.2010","volume":"300","author":"C Lau","year":"2011","unstructured":"Lau, C., Lytle, C., Straus, D. S. & DeFea, K. A. Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium. Am. J. Physiol. Cell Physiol. 300, C113\u2013C123 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1129_CR280","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOH.0b013e32834115d1","volume":"18","author":"U Meyer-Hoffert","year":"2011","unstructured":"Meyer-Hoffert, U. & Wiedow, O. Neutrophil serine proteases: mediators of innate immune responses. Curr. Opin. Hematol. 18, 19\u201324 (2011).","journal-title":"Curr. Opin. Hematol."},{"key":"1129_CR281","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/417091a","volume":"417","author":"Y Weinrauch","year":"2002","unstructured":"Weinrauch, Y., Drujan, D., Shapiro, S. D., Weiss, J. & Zychlinsky, A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 417, 91\u201394 (2002).","journal-title":"Nature"},{"key":"1129_CR282","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","volume":"285","author":"CE Hughes","year":"2018","unstructured":"Hughes, C. E. & Nibbs, R. J. B. A guide to chemokines and their receptors. FEBS J. 285, 2944\u20132971 (2018).","journal-title":"FEBS J."},{"key":"1129_CR283","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.4049\/jimmunol.144.6.2253","volume":"144","author":"LW Heck","year":"1990","unstructured":"Heck, L. W. et al. Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J. Immunol. 144, 2253\u20132257 (1990).","journal-title":"J. Immunol."},{"key":"1129_CR284","doi-asserted-by":"publisher","first-page":"eadk2536","DOI":"10.1126\/science.adk2536","volume":"385","author":"Q Lu","year":"2024","unstructured":"Lu, Q. et al. A host-adapted auxotrophic gut symbiont induces mucosal immunodeficiency. Science 385, eadk2536 (2024).","journal-title":"Science"},{"key":"1129_CR285","doi-asserted-by":"publisher","first-page":"459640","DOI":"10.1155\/2014\/459640","volume":"2014","author":"M Cohen-Mazor","year":"2014","unstructured":"Cohen-Mazor, M., Mazor, R., Kristal, B. & Sela, S. Elastase and cathepsin G from primed leukocytes cleave vascular endothelial cadherin in hemodialysis patients. Biomed. Res. Int. 2014, 459640 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1129_CR286","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1074\/jbc.M300351200","volume":"278","author":"B Hermant","year":"2003","unstructured":"Hermant, B. et al. Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J. Biol. Chem. 278, 14002\u201314012 (2003).","journal-title":"J. Biol. Chem."},{"key":"1129_CR287","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.yexcr.2009.07.031","volume":"315","author":"N Kondo","year":"2009","unstructured":"Kondo, N., Ogawa, M., Wada, H. & Nishikawa, S. Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells. Exp. Cell Res. 315, 2879\u20132887 (2009).","journal-title":"Exp. Cell Res."},{"key":"1129_CR288","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1161\/01.RES.0000057386.15390.A3","volume":"92","author":"SW Klarenbach","year":"2003","unstructured":"Klarenbach, S. W., Chipiuk, A., Nelson, R. C., Hollenberg, M. D. & Murray, A. G. Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases. Circ. Res. 92, 272\u2013278 (2003).","journal-title":"Circ. Res."},{"key":"1129_CR289","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.it.2007.09.001","volume":"28","author":"V Shpacovitch","year":"2007","unstructured":"Shpacovitch, V., Feld, M., Bunnett, N. W. & Steinhoff, M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol. 28, 541\u2013550 (2007).","journal-title":"Trends Immunol."},{"key":"1129_CR290","doi-asserted-by":"publisher","first-page":"103387","DOI":"10.1016\/j.isci.2021.103387","volume":"24","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. The role of protease-activated receptor 1 signaling in CD8 T cell effector functions. iScience 24, 103387 (2021).","journal-title":"iScience"},{"key":"1129_CR291","doi-asserted-by":"publisher","first-page":"101981","DOI":"10.1016\/j.isci.2020.101981","volume":"24","author":"H Wilkinson","year":"2021","unstructured":"Wilkinson, H. et al. PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responses. iScience 24, 101981 (2021).","journal-title":"iScience"},{"key":"1129_CR292","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.molimm.2019.08.004","volume":"114","author":"G Garcia-Gonzalez","year":"2019","unstructured":"Garcia-Gonzalez, G. et al. Triggering of protease-activated receptors (PARs) induces alternative M2 macrophage polarization with impaired plasticity. Mol. Immunol. 114, 278\u2013288 (2019).","journal-title":"Mol. Immunol."},{"key":"1129_CR293","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00210-020-02014-w","volume":"394","author":"A Barra","year":"2021","unstructured":"Barra, A. et al. Protease-activated receptor 4 plays a role in lipopolysaccharide-induced inflammatory mechanisms in murine macrophages. Naunyn Schmiedebergs Arch. Pharmacol. 394, 853\u2013862 (2021).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"1129_CR294","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.coph.2006.05.001","volume":"6","author":"G Cirino","year":"2006","unstructured":"Cirino, G. & Vergnolle, N. Proteinase-activated receptors (PARs): crossroads between innate immunity and coagulation. Curr. Opin. Pharmacol. 6, 428\u2013434 (2006).","journal-title":"Curr. Opin. Pharmacol."},{"key":"1129_CR295","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/1354750X.2013.787544","volume":"18","author":"E Kashuba","year":"2013","unstructured":"Kashuba, E., Bailey, J., Allsup, D. & Cawkwell, L. The kinin\u2013kallikrein system: physiological roles, pathophysiology and its relationship to cancer. Biomark. Biomark. 18, 279\u2013296 (2013).","journal-title":"Biomark. Biomark."},{"key":"1129_CR296","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1172\/JCI117330","volume":"94","author":"T Imamura","year":"1994","unstructured":"Imamura, T., Pike, R. N., Potempa, J. & Travis, J. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein\/kinin pathway. J. Clin. Invest. 94, 361\u2013367 (1994).","journal-title":"J. Clin. Invest."},{"key":"1129_CR297","doi-asserted-by":"publisher","first-page":"18902","DOI":"10.1016\/S0021-9258(19)37046-2","volume":"267","author":"JA Wingrove","year":"1992","unstructured":"Wingrove, J. A. et al. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J. Biol. Chem. 267, 18902\u201318907 (1992).","journal-title":"J. Biol. Chem."},{"key":"1129_CR298","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0090-1229(92)90065-V","volume":"62","author":"YQ Hong","year":"1992","unstructured":"Hong, Y. Q. & Ghebrehiwet, B. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin. Immunol. Immunopathol. 62, 133\u2013138 (1992).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"1129_CR299","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0024-3205(01)01519-3","volume":"70","author":"R Ducroc","year":"2002","unstructured":"Ducroc, R. et al. Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop. Life Sci. 70, 1359\u20131367 (2002).","journal-title":"Life Sci."},{"key":"1129_CR300","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1158\/1541-7786.514.2.9","volume":"2","author":"D Darmoul","year":"2004","unstructured":"Darmoul, D., Gratio, V., Devaud, H., Peiretti, F. & Laburthe, M. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol. Cancer Res. 2, 514\u2013522 (2004).","journal-title":"Mol. Cancer Res."},{"key":"1129_CR301","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072383","volume":"8","author":"Y Ma","year":"2013","unstructured":"Ma, Y. et al. MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation. PLoS ONE 8, e72383 (2013).","journal-title":"PLoS ONE"},{"key":"1129_CR302","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.biocel.2007.11.026","volume":"40","author":"G Jenkins","year":"2008","unstructured":"Jenkins, G. The role of proteases in transforming growth factor-beta activation. Int. J. Biochem. Cell Biol. 40, 1068\u20131078 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1129_CR303","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1083\/jcb.200409115","volume":"169","author":"S Lee","year":"2005","unstructured":"Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D. & Iruela-Arispe, M. L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681\u2013691 (2005).","journal-title":"J. Cell Biol."},{"key":"1129_CR304","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1096\/fj.02-0316com","volume":"17","author":"YJ Yin","year":"2003","unstructured":"Yin, Y. J. et al. Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J. 17, 163\u2013174 (2003).","journal-title":"FASEB J."},{"key":"1129_CR305","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1182\/blood-2007-07-101048","volume":"111","author":"HH Versteeg","year":"2008","unstructured":"Versteeg, H. H. et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 111, 190\u2013199 (2008).","journal-title":"Blood"},{"key":"1129_CR306","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/jth.15115","volume":"19","author":"PG Schweickert","year":"2021","unstructured":"Schweickert, P. G. et al. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. J. Thromb. Haemost. 19, 161\u2013172 (2021).","journal-title":"J. Thromb. Haemost."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01129-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:02:23Z","timestamp":1766581343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01129-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":306,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1038\/s41575-025-01129-w","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"11 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors hold patents relevant to the topic of this Review (patents\u00a0US20150073125 (to\u00a0N.V.),\u00a0US9,688,742 (to\u00a0C.D. and N.V.),\u00a0US11,692,045 (to\u00a0C.D. and N.V.) and\u00a0WO\/2025\/132833 (to\u00a0C.D. and N.V.)).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}